Medtronic (MDT) Research & Development (2014 - 2026)

Medtronic has disclosed Research & Development across 13 years of filings, most recently posting $722.0 million for Q1 2026.

• Research & Development for Q1 2026 came in at $722.0 million, up 6.96% year-over-year; the trailing twelve-month figure through Jan 2026 was $2.9 billion (up 5.99% YoY), and the FY2025 annual result was $2.7 billion, changed 0.11% from the prior year.
• Research & Development came in at $722.0 million for Q1 2026 at Medtronic, down from $754.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $754.0 million in Q4 2025 to a low of $641.0 million in Q2 2023.
• The 5-year median for Research & Development is $684.0 million (2025), against an average of $687.5 million.
• Peak annual rise in Research & Development reached 11.15% in 2022, while the deepest fall reached 7.73% in 2022.
• Medtronic's Research & Development stood at $676.0 million in 2022, then rose by 3.25% to $698.0 million in 2023, then declined by 0.14% to $697.0 million in 2024, then advanced by 8.18% to $754.0 million in 2025, then declined by 4.24% to $722.0 million in 2026.
• The last three Research & Development figures came in at $722.0 million (Q1 2026), $754.0 million (Q4 2025), and $726.0 million (Q3 2025), per Business Quant data.